Ligand validation:2VC7

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VC7_GOL_A_1317	73%	87%	0.115	0.942	0.38	0.32	-	-	0	0	100%	1
2VC7_GOL_C_1317	55%	87%	0.166	0.935	0.36	0.33	-	-	0	0	100%	1
2VC7_GOL_A_1323	48%	89%	0.147	0.89	0.37	0.27	-	-	1	0	100%	1
2VC7_GOL_C_1327	45%	91%	0.162	0.892	0.37	0.22	-	-	0	0	100%	1
2VC7_GOL_D_1324	36%	87%	0.144	0.837	0.34	0.36	-	-	0	0	100%	1
2VC7_GOL_D_1320	36%	90%	0.174	0.867	0.36	0.26	-	-	0	0	100%	1
2VC7_GOL_B_1327	34%	89%	0.21	0.892	0.39	0.26	-	-	0	0	100%	1
2VC7_GOL_B_1323	32%	89%	0.164	0.837	0.35	0.3	-	-	0	0	100%	1
2VC7_GOL_C_1320	31%	86%	0.195	0.864	0.37	0.34	-	-	2	0	100%	1
2VC7_GOL_B_1317	31%	87%	0.186	0.852	0.38	0.31	-	-	0	0	100%	1
2VC7_GOL_D_1317	27%	91%	0.199	0.843	0.36	0.23	-	-	0	0	100%	1
2VC7_GOL_B_1325	26%	90%	0.21	0.851	0.36	0.25	-	-	0	0	100%	1
2VC7_GOL_B_1321	24%	90%	0.23	0.862	0.36	0.24	-	-	0	0	100%	1
2VC7_GOL_A_1324	24%	90%	0.204	0.833	0.37	0.25	-	-	2	0	100%	1
2VC7_GOL_D_1321	21%	92%	0.213	0.822	0.36	0.17	-	-	0	0	100%	1
2VC7_GOL_A_1332	21%	88%	0.19	0.795	0.35	0.31	-	-	0	0	100%	1
2VC7_GOL_A_1334	20%	87%	0.21	0.809	0.36	0.33	-	-	0	0	100%	1
2VC7_GOL_B_1322	17%	89%	0.193	0.769	0.37	0.26	-	-	0	0	100%	1
2VC7_GOL_C_1319	16%	91%	0.27	0.842	0.4	0.18	-	-	1	0	100%	1
2VC7_GOL_A_1333	16%	90%	0.218	0.786	0.37	0.24	-	-	0	0	100%	1
2VC7_GOL_A_1321	15%	91%	0.197	0.758	0.37	0.22	-	-	0	0	100%	1
2VC7_GOL_A_1326	14%	90%	0.188	0.738	0.36	0.25	-	-	0	0	100%	1
2VC7_GOL_A_1325	7%	88%	0.327	0.775	0.37	0.3	-	-	0	0	100%	1
2VC7_GOL_A_1329	6%	92%	0.285	0.725	0.37	0.18	-	-	1	0	100%	1
2VC7_GOL_A_1328	6%	91%	0.274	0.706	0.38	0.21	-	-	2	0	100%	1
2VC7_GOL_C_1324	4%	92%	0.321	0.709	0.37	0.17	-	-	1	0	100%	1
2VC7_GOL_C_1325	4%	91%	0.261	0.646	0.38	0.21	-	-	0	0	100%	1
2VC7_GOL_A_1319	4%	91%	0.213	0.581	0.33	0.26	-	-	0	0	100%	1
4KES_GOL_D_404	94%	92%	0.069	0.97	0.35	0.19	-	-	0	0	100%	1
4KER_GOL_A_404	87%	88%	0.079	0.949	0.31	0.35	-	-	0	0	100%	1
4KET_GOL_A_404	87%	90%	0.082	0.952	0.32	0.3	-	-	0	0	100%	1
5VSA_GOL_B_404	86%	52%	0.099	0.967	0.83	1.03	-	-	0	0	100%	1
4KEZ_GOL_C_403	86%	89%	0.076	0.943	0.24	0.4	-	-	3	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.